We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$390M
AUM Growth
+$46.9M
Cap. Flow
+$17M
Cap. Flow %
4.37%
Top 10 Hldgs %
58.21%
Holding
38
New
5
Increased
16
Reduced
11
Closed
5

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$10.9M
2
ILMN icon
Illumina
ILMN
+$9.8M
3
RMD icon
ResMed
RMD
+$6.4M
4
HSP
HOSPIRA INC
HSP
+$6.06M
5
SHPG
Shire pic
SHPG
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 76.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$382B
$6.09M 1.56%
85,000
+45,000
+113% +$3.22M
IRWD icon
27
Ironwood Pharmaceuticals
IRWD
$611M
$5.01M 1.28%
+505,051
New +$4.95M
OPTR
28
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
$4.74M 1.22%
376,393
+35,000
+10% +$464K
ACH
29
Accendra Health
ACH
$240M
$4.39M 1.13%
126,984
-12,400
-9% -$434K
HSP
30
DELISTED
HOSPIRA INC
HSP
$2.98M 0.76%
76,000
-152,000
-67% -$6.06M
UTHR icon
31
United Therapeutics
UTHR
$26.3B
$2.88M 0.74%
36,510
+4,200
+13% +$307K
MNTA
32
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.69M 0.69%
186,800
+21,800
+13% +$334K
SPPI
33
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$419K 0.11%
50,000
ILMN icon
34
Illumina
ILMN
$29.4B
-134,668
Closed -$9.8M
RMD icon
35
ResMed
RMD
$28.3B
-141,770
Closed -$6.4M
TMO icon
36
Thermo Fisher Scientific
TMO
$211B
-5,000
Closed -$423K
DNDN
37
DELISTED
DENDREON CORPORATION
DNDN
-345,000
Closed -$1.42M
SHPG
38
DELISTED
Shire pic
SHPG
-60,000
Closed -$5.71M

Similar funds

Sector Gamma AS's Q3 2013 Portfolio in Review

As of Q3 2013, Sector Gamma AS held 38 positions worth $390M, up 14% from $343M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sector Gamma AS deployed $17M of net new capital in Q3 2013, opening 5 new positions and adding to 16 existing holdings. Its largest new stake was Edwards Lifesciences: 1,080,000 shares worth $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 80% a quarter earlier.

On the sell side, the largest reduction was Boston Scientific, an estimated $10.9M trimmed.

  • Sector Gamma AS's largest Q3 2013 buy was Edwards Lifesciences: 1,080,000 shares worth $12.5M.
  • Sector Gamma AS added most to Eli Lilly in Q3 2013, an estimated $9.37M increase.
  • Sector Gamma AS's biggest Q3 2013 reduction was Boston Scientific, cutting an estimated $10.9M.
  • Sector Gamma AS fully exited Illumina in Q3 2013, selling an estimated $9.8M.
  • Sector Gamma AS's ten largest holdings make up 58% of its $390M portfolio in Q3 2013.
  • Sector Gamma AS opened 5 new positions and closed 5 in Q3 2013.
  • Sector Gamma AS's portfolio value rose 14% quarter-over-quarter to $390M.

Based on Sector Gamma AS's 13F filing for Q3 2013, filed 16 Dec 2013.